miR-148a, upon induction, promotes the GBM pathogenesis by activating the TGF-β signalling by promoting the expression of pSMAD3 and downregulating the negative regulators (QKI and SKI) of the TGF-β signalling [82]. The gene discussed is SKI; the disease is glioblastoma.